RxDoctor Payments Data

Granger Scruggs, MD

Radiation Oncology · Dallas, TXNPI 1598896417

Payments from drug & device makers

$303in general payments, 2019–2025

Across 9 payments — averaging $33.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$146
  • GSK$118
  • Novocure Inc.$39

What the payments were for

  • Food & beverage$303100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis6$146
GSK1$118
Novocure Inc.2$39

How this compares

$303 in reported general payments places this provider in the 30th percentile of 418 radiation oncology providers in Texas.

See all radiation oncology providers in Texas

Medicare billing

Part B allowed, 2024
$2,424,927
Medicare patients
306
Services billed
12,168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen21$395

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →